Independent Labs, Institutes, and Centers (Dean of Research)


Showing 21-40 of 218 Results

  • Alberto Salleo

    Alberto Salleo

    Hong Seh and Vivian W. M. Lim Professor and Professor, by courtesy, of Photon Science

    Current Research and Scholarly InterestsNovel materials and processing techniques for large-area and flexible electronic/photonic devices. Polymeric materials for electronics, bioelectronics, and biosensors. Electrochemical devices for neuromorphic computing. Defects and structure/property studies of polymeric semiconductors, nano-structured and amorphous materials in thin films. Advanced characterization techniques for soft matter.

  • Joshua Salomon

    Joshua Salomon

    Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies

    BioJoshua Salomon is a Professor of Health Policy, a core faculty member in the Center for Health Policy, and Senior Fellow at the Freeman Spogli Institute for International Studies. His research focuses on public health policy and priority-setting, within three main substantive areas: (1) modeling patterns and trends in major causes of global mortality and disease burden; (2) evaluation of health interventions and policies; and (3) measurement and valuation of health outcomes.

    Dr. Salomon is an investigator on projects funded by the Centers for Disease Control and Prevention, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost effectiveness of new health technologies.

    He is Director of the Prevention Policy Modeling Lab, which is a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Prior to joining the Stanford faculty, Dr. Salomon was Professor of Global Health at Harvard T.H. Chan School of Public Health.

    For more information on the Prevention Policy Modeling Lab visit ppml.stanford.edu.

  • Julia Salzman

    Julia Salzman

    Associate Professor of Biomedical Data Science, of Biochemistry and, by courtesy, of Statistics and of Biology

    Current Research and Scholarly Interestsstatistical computational biology focusing on splicing, cancer and microbes

  • Jacinda Sampson

    Jacinda Sampson

    Clinical Professor, Adult Neurology

    BioDr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.

  • Niyatee Samudra, MD

    Niyatee Samudra, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Samudra is a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She is one of a small number of neurologists nationwide who is board-certified and fellowship-trained in epilepsy as well as in behavioral neurology and neuropsychiatry.

    Dr. Samudra leads a clinic at Stanford for the treatment of older adults with epilepsy. In addition, she has clinical interests in the treatment of atypical Parkinsonism and in women’s brain health across the lifespan. She co-leads the CurePSP Center of Care and is a member of the Menopause Collaborative of Practice at Stanford. Her varied research interests include clinical trials in neurodegenerative disease and in epilepsy; improving treatment for older adults with epilepsy; understanding the cognitive and neuropsychiatric consequences of epilepsy; and treatment of neuropsychiatric symptoms in neurodegenerative disorders.

    Prior to coming to Stanford, Dr. Samudra was a fellow in behavioral neurology and neuropsychiatry at the University of California, San Francisco, as well as in epilepsy and clinical neurophysiology at Vanderbilt University Medical Center. She completed her undergraduate degree at MIT and obtained her medical degree and neurology residency training at the University of Texas Southwestern Medical Center.

    Dr. Samudra has published in the Journal of Alzheimer’s Disease; Current Neurology and Neuroscience Reports; Journal of the Neurological Sciences; Seizure; and Epilepsy and Behavior, among others. She is a member of the American Epilepsy Society and the American Academy of Neurology.

  • Juan G. Santiago

    Juan G. Santiago

    Charles Lee Powell Foundation Professor

    Current Research and Scholarly Interestshttp://microfluidics.stanford.edu/Projects/Projects.html

  • Serena Sanulli

    Serena Sanulli

    Assistant Professor of Genetics

    Current Research and Scholarly InterestsWe study the organizing principles of the genome and how these principles regulate cell identity and developmental switches. We combine Biochemistry and Biophysical methods such as NMR and Hydrogen-Deuterium Exchange-MS with Cell Biology, and Genetics to explore genome organization across length and time scales and understand how cells leverage the diverse biophysical properties of chromatin to regulate genome function.

  • Kavita Sarin, MD, PhD

    Kavita Sarin, MD, PhD

    Professor of Dermatology

    Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.

  • Peter Sarnow

    Peter Sarnow

    Burt and Marion Avery Professor of Immunology
    On Partial Leave from 03/16/2025 To 10/01/2025

    Current Research and Scholarly InterestsOur laboratory studies virus-host interactions with an emphasis microRNA-mediated gene regulation and on translational control. The mechanism by which a liver-specific microRNA regulates hepatitis C virus genome replication is under intense scrutiny. In addition, the mechanism of internal ribosome entry in certain cellular and viral mRNAs and its biological role in growth and development is being investigated.

  • Ansuman Satpathy

    Ansuman Satpathy

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.

  • Elizabeth Sattely

    Elizabeth Sattely

    Associate Professor of Chemical Engineering

    BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.

  • Alan F. Schatzberg

    Alan F. Schatzberg

    Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.

  • Londa Schiebinger

    Londa Schiebinger

    John L. Hinds Professor of the History of Science

    BioLonda Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.

    Professor Schiebinger received her Ph.D. from Harvard University in 1984 and is a leading international authority on gender in science and technology. Over the past thirty years, Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.

    Londa Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the findings at the United Nations in New York, February 2011 with an update spring 2014. In 2022, she prepared the background paper for the United Nations 67th session of the Commission on the Status of Women’s priority theme, Innovation and Technological Change, and Education in the Digital Age for Achieving Gender Equality and The Empowerment of all Women and Girls. Since 2023, Gendered Innovations has been a member of the UNFPA Equity 2030 Alliance.

    In 2011-2014, Schiebinger entered into major collaborations with the European Commission and the U.S. National Science Foundation to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the U.S., Europe, Canada, and Asia, and was presented at the European Parliament, July 2013 as Gendered Innovations: How Gender Analysis Contributes to Research. In 2018-2020, Schiebinger directed the European Commission Expert Group to produce Gendered Innovations 2: How Inclusive Analysis Contributes to Research and Innovation. Institutes for Gendered Innovations research opened in Soeul, South Korea, in 2015 and in Tokyo, Japan, in 2022.

    Schiebinger’s work has been featured in Science: A Framework for Sex, Gender, and Diversity Analysis in Research: Funding Agencies Have Ample Room to Improve Their Policies (2022); Nature: Sex and Gender Analysis Improves Science and Engineering (2019); Nature: Design AI so that it's Fair (2018); Nature: Accounting for Sex and Gender Makes for Better Science (2020).

    Her work in the eighteenth century investigates the circulation of knowledge in the Atlantic World. Her Secret Cures of Slaves: People, Plants, and Medicine in the Eighteenth-Century Atlantic World reconceptualizes research in four areas: first and foremost knowledge of African contributions to early modern science; the historiography of race in science; the history of human experimentation; and the role of science in the eighteenth-century Atlantic world. Her prize-winning Plants and Empire: Colonial Bioprospecting in the Atlantic World investigates women's indigenous knowledge of abortifacients and why this knowledge did not travel.

    Londa Schiebinger has been the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and John Simon Guggenheim Fellowship. She was awarded an honorary doctorate from the Vrije Universiteit Brussel, Belgium (2013), the Faculty of Science, Lund University, Sweden (2017), and the University of Valencia, Spain (2018); the Berlin Falling Walls Breakthrough Winner in Science & Innovation Management (2022). Her work has been translated into numerous languages. In 2022/23, she served as an advisor to the Berlin University Alliance.

  • Alain Schläpfer

    Alain Schläpfer

    Social Science Research Scholar

    BioAlain Schläpfer is a Social Science Research Scholar at the Center on Democracy, Development and the Rule of Law, and a Lecturer in the Ford Dorsey Master's in International Policy. His research examines the evolution of cooperation among individuals and groups, with a particular emphasis on the role of reputational concerns. He also investigates the formation of preferences and of cultural norms, as well as their effects on behavior and long term outcomes. Alain's research has been published in journals in political science, economics and biology, and makes use of formal modelling, causal identification and computer simulations. Originally from Switzerland, Alain received his PhD from Universitat Pompeu Fabra in Barcelona, Spain.